TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer

Author:

Gao Caiyun,Yao Hongyu,Liu Huimin,Feng Yanying,Yang ZhijunORCID

Funder

Guangxi medical high-level backbone personnel training“139” Project

Guangxi Natural Science Foundation

Special Fund of the 17th Guangxi New Century “Ten, Hundred, Thousand” Talent Project

the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Reference21 articles.

1. Yang ZJ, Yang G, Jiang YM, Ran YL, Yang ZH, Zhang W, Zhang JQ, Pan ZM, Li L. Screening and sero-immunoscreening of ovarian epithelial cancer associative antigens. Zhonghua Fu Chan Ke Za Zhi. 2007;42(12):834–9.

2. Yang ZJ, Yang G, Jiang YM, Ran YL, Yang ZH, Zhang W, Zhang JQ, Pan ZM, Li L. Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA (125) in detecting and monitoring ovarian cancer. Zhonghua Fu Chan Ke Za Zhi. 2011;46(2):113–8.

3. Xue L, Yu X, Jiang X, Deng X, Mao L, Guo L, Fan J, Fan Q, Wang L, Lu SH. TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141. Oncotarget. 2017;8(12):19274–84.

4. Cao J, Yang JC, Ramachandran V, Arumugam T, Deng DF, Li ZS, Xu LM, Logsdon CD. TM4SF1 regulates pancreatic Cancer migration and invasion in vitro and in vivo. Cell Physiol Biochem. 2016;39(2):740–50.

5. Huang YK, Fan XG, Qiu F. TM4SF1 promotes proliferation, invasion, and metastasis in human liver Cancer cells. Int J Mol Sci. 2016;17(5):661.

Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3